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Abstract 
Introduction: The aim of this study was to compare plasma oxytocin levels in obese women of childbearing age with non-obese women of 
childbearing age, and to investigate the relationship between plasma oxytocin levels and metabolic parameters (including blood glucose, 
insulin resistance, blood lipid, and blood pressure). 
Material and methods: A total of 151 obese women of childbearing age and 160 non-obese women of childbearing age were enrolled in 
this study. Plasma oxytocin levels were measured by electrochemiluminescence immunoassays. Height, body weight, body mass index 
(BMI), fasting blood glucose (FBG), fasting insulin (FI), homeostasis model assessment for insulin resistance (HOMA-IR), total triglycerides 
(TG), total cholesterol (TC), low-density lipoprotein-C (LDL-C), high-density lipoprotein-C (HDL-C), systolic blood pressure (SBP), and 
diastolic blood pressure (DBP) were measured in all subjects. Quantile regression analysis was used to analyse the associations of plasma 
oxytocin levels with FBG, FI, HOMA-IR, TG, TC, LDL-C, HDL-C, SBP, and DBP. 
Results: In obese women of childbearing age, plasma oxytocin levels were lower compared with non-obese controls. After adjusting for 
age, quantile regression analysis showed that the plasma oxytocin levels were inversely associated with HOMA-IR at the quantile level 
between 0.27 and 0.79 (i.e. the HOMA-IR level of 2.11 and 3.07, respectively), the plasma oxytocin levels were inversely associated with 
TC after the quantile level of 0.21 (i.e. the TC level of 3.78 ), and the plasma oxytocin levels were inversely associated with LDL-C at all 
quantile levels of LDL-C. In addition, the plasma oxytocin levels showed a positive association with HDL-C at all quantile levels of HDL-C. 
No significant associations were found between the plasma oxytocin levels and FBG, FI, TG, SBP, and DBP.
Conclusions: Oxytocin deficiency was common in obese women of childbearing age. Oxytocin showed negative correlation with HOMA-IR, 
TC, and LDL-C, while it showed positive association with HDL-C. Our findings suggest that oxytocin played an important role in inhibit-
ing metabolic disorders associated with obesity in women of childbearing age. (Endokrynol Pol 2019; 70 (5): 417–422)
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Introduction
The worldwide upward trend in obesity has been 
dramatic, the prevalence of obesity has nearly tripled 
since 1975, and in 2016, more than 1.9 billion adults 
were overweight, 39% of women aged 18 and over 
were overweight, according to a report by the World 
Health Organisation (WHO) [1]. Obesity in women of 
childbearing age is association with increasing risk of 
a number of adverse pregnancy and birth outcomes, 
including gestational diabetes, gestational hyperten-
sion, foetal macrosomia, miscarriage, preterm birth, 
birth defects, and infant mortality [2–5]. Obese women 
are also at greater risk than obese men of developing 
many chronic diseases, including metabolic syndrome, 
type 2 diabetes, essential hypertension, dyslipidaemia, 
and cardiovascular diseases [6, 7]. The common risk 
factors of becoming overweight or obese in women of 
reproductive age include order of births, pregnancy and 
breast-feeding triggers physiological changes, genetic 
and ethnic reason, socioeconomic status and abnormal 
endocrine function [8–10]. 
Oxytocin, a hypothalamic hormone that enters the 
peripheral circulation through the posterior pituitary, 
regulates a range of physiological processes, including 
reducing caloric intake, increasing energy expenditure, 
improving fat metabolism, and maintaining glucose 
homeostasis and insulin sensitivity [11–13]. Some stud-
ies have confirmed the association of plasma oxytocin 
with obesity, and oxytocin may play an important role 
in control of body weight in women [14]. Decreased 
oxytocin concentration is directly correlated with 
hypertension, dyslipidaemia, insulin resistance, and 
type 2 diabetes mellitus [15–17]. However, few studies 
have directly examined the associations of oxytocin 
with obesity in women of reproductive years because 
normal ovarian function and oestradiol concentration 
may prevent women from being obese. Nonetheless, 
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Statistical analysis
Statistical Package for the Social Sciences, version 22.0 (SPSS Inc., 
Chicago, IL, USA) was used for statistical analysis. The general 
variables of the subjects across the two study groups (i.e. the obese 
women group and the non-obese women group) were expressed 
as means and standard deviations. The variables were compared 
using two-sample t-test. Differences were considered significant at 
p < 0.05 for two sides. Quantile regression analysis [23] was used 
to analyse the associations of plasma oxytocin levels with obesity-
related parameters in two groups. The regression coefficients of 
the variable (plasma oxytocin) in the quantile regression model 
differ across the varying quantile levels of FPG, FI, HOMA-IR, TC, 
TG, LDL-C, HDL-C, SBP, and DBP. The figures in this study were 
drawn using GraphPad Prism version 7 (GraphPad Software, Inc., 
La Jolla, CA, USA). 
Results
Clinical and laboratory characteristics of the two 
study groups 
From all 311 participants, there were 151 subjects 
(48.55%) in the obese women group and 160 subjects 
(51.45%) in the non-obese women group. The descrip-
tive statistics of the characteristics are shown in Table I. 
The obese women group had higher BMI (p < 0.001), 
higher FPG (p = 0.005), higher TC (p < 0.001), higher 
LDL-C (p < 0.001), higher SBP (P = 0.008), lower oxy-
tocin (p < 0.001), and lower HDL-C (p < 0.001) levels 
compared with the non-obese women group. As for all 
the other characteristics, including age, FI, and DBP, the 
differences between two groups did not reach statistical 
significance (p > 0.05).
Associations of plasma oxytocin levels 
with obesity-related parameters 
Table II shows the coefficient estimation with 95% CI 
for the associations of plasma oxytocin levels with 
HOMA-IR, TC, LDL-C, and HDL-C at varying quantile 
levels of these variables. After adjusting for age, quantile 
regression analysis showed that the plasma oxytocin 
levels were inversely associated with HOMA-IR at the 
quantile level between 0.27 and 0.79 (i.e. the HOMA-IR 
level of 2.11 and 3.07, respectively), the plasma oxyto-
cin levels were inversely associated with TC after the 
quantile level of 0.21 (i.e. the TC level of 3.78 ), and the 
plasma oxytocin levels were inversely associated with 
LDL-C at all quantile levels of LDL-C. In addition, the 
plasma oxytocin levels showed a positive association 
with HDL-C at all quantile levels of HDL-C. No signifi-
cant associations were found between plasma oxytocin 
levels and FBG, FI, TG, SBP, and DBP. 
The plot in Figures 1–4 shows the coefficients for the 
associations of plasma oxytocin levels with HOMA-IR, 
TC, LDL-C, and HDL-C across the selected quantile 
levels of these variables. The grey area represents the 
95% CI of the coefficients, the black curve represents the 
estimated coefficients, and the dotted line represents 
some studies suggested that ovarian function is slightly 
lower in obese women than in healthy control subjects 
of young reproductive age, although ovarian reserve 
parameters are in normal reference range [18, 19]. 
In addition, some studies also revealed that lacking 
oestradiol can blunt oxytocin expression, decreasing 
circulation levels of oxytocin, and inhibiting signalling 
in pre-autonomic areas of the hypothalamus [20]. 
Therefore, we hypothesised that the plasma oxy-
tocin may decrease in obese women of childbearing age, 
thus contributing to obesity, and the decreased plasma 
oxytocin levels may be associated with obesity-related 
parameters, including blood glucose, insulin resistance, 
blood lipids, and blood pressure.
Material and methods
Subjects
From April 2017 to October 2018, 151 obese women of childbear-
ing age (18 to 45 years) were selected randomly from among 
out-patients of Heilongjiang provincial hospital, Harbin, China. 
160 non-obese women controls aged 18–45 years were selected 
randomly from a physical examination centre at the same time in 
the same hospital. Subjects with thyroid diseases, adrenal diseases, 
pituitary diseases, ovarian diseases, heart failure, severe hepatic or 
renal diseases, severe gastrointestinal diseases, malignant tumour, 
hypertension, diabetes mellitus, or mental illness were excluded 
from this study. Pregnant or lactating women were also excluded 
from this study. 
Definition 
BMI was classified into the following three categories: 18.5–23.9 kg/m2 
(normal weight), 24.0–27.9 kg/m2 (overweight), and ≥ 28.0 kg/m2 
(obesity) [21]. In this study, we excluded pathological obesity 
caused by metabolic or endocrine diseases. In addition, women 
of childbearing age were those aged 18–45 years with normal 
menstrual cycle.
Anthropometric and laboratory measurement
Height and weight were measured using an ultrasonic electronic 
height and weight measuring instrument (Umron Co., Beijing, 
China). Blood samples were obtained from all subjects at 8 a.m. after 
at least an eight-hour overnight fast. Plasma oxytocin and FI levels 
were determined using electrochemiluminescence immunoassays 
(Roche Diagnostics, Mannheim, Germany) and FPG, TG, TC, LDL-C, 
and HDL-C were assayed by automatic biochemical analyser 
(Hitachi, Ltd., Tokyo, Japan) in the Department of Experimental 
Diagnosis, Heilongjiang Provincial Hospital, Harbin, China. Blood 
pressure was measured from right arm in a sitting position after the 
participants had rested for 30 minutes, using a mercury sphygmo-
manometer. BMI was calculated according to the following formula: 
weight (kg) / height (m)2.
HOMA-IR was calculated according to this formula: 
FI (mIU/L) × FPG (mmol/L) /22.5.
Medical ethical approval 
This study was approved by the medical Ethics Committee of Hei-
longjiang Provincial Hospital. Written consent to participate in this 
study was obtained from all participants. Only those who signed 
the consent form were enrolled in the study. All study protocols 
were carried out in accordance with the declaration of Helsinki [22].
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the coefficient=0. We found the association between 
plasma oxytocin levels and HOMA-IR at the quantile 
level between 0.27 and 0.79 (i.e. the HOMA-IR levels 
of 2.11 and 3.07, respectively). An inverse association 
of plasma oxytocin levels with TC was found after the 
quantile level of 0.21 (i.e. the TC level of 3.78), and it 
became stronger after that level. The inverse association 
of plasma oxytocin levels with LDL-C was seen at all 
quantile levels and became stronger after the quantile 
level of 0.32 (i.e. the LDL level of 1.91). The plasma oxy-
tocin levels showed a positive association with HDL-C 
at all quantile levels of HDL-C, and the correlation was 
Table I. Comparison of clinical and laboratory characteristics between obese women and non-obese women
Characteristics Total (n = 311)
Non-obese women group 
(n = 160)
Obese women group 
(n = 151) p-value
Age [years] 32.72 ± 7.37 32.74 ± 7.04 32.70 ± 7.72 0.966
BMI [kg/m2] 25.89 ± 3.93 22.51 ± 2.20 29.48 ± 1.29* < 0.001
FPG [mmol/L] 5.01 ± 0.61 4.91 ± 0.59 5.11 ± 0.62* 0.005
FI [mU/mL] 11.41 ± 2.24 11.46 ± 2.15 11.36 ± 2.33 0.703
HOMA-IR 2.54 ± 0.58 2.50 ± 0.57 2.57 ± 0.59 0.284
TG [mmol/L] 1.89 ± 0.57 1.87 ± 0.41 1.91 ± 0.70 0.486
TC [mmol/L] 4.68 ± 1.02 4.29 ± 0.68 5.09 ± 1.15* < 0.001
LDL-C [mmol/L] 2.17 ± 0.77 1.78 ± 0.52 2.58 ± 0.77* < 0.001
HDL [mmol/L] 1.38 ± 0.39 1.55 ± 0.40 1.19 ± 0.29* < 0.001
DBP [mm Hg] 70.23 ± 8.03 69.64 ± 7.68 70.87 ± 8.36 0.177
SBP [mm Hg] 113.13 ± 10.74 111.55 ± 11.00 114.79 ± 10.23* 0.008
Oxytocin [ng/mL] 2.52 ± 0.82 2.96 ± 0.51 2.04 ± 0.82* < 0.001
BMI — body mass index; FPG — fasting plasma glucose; FI — fasting plasma insulin; HOMA-IR — homeostatic model assessment for insulin resistance; TG — 
triglyceride; TC — total cholesterol; LDL-C — low-density lipoprotein cholesterol; HDL — high-density lipoprotein; DBP — diastolic blood pressure; SBP — systolic 
blood pressure. Variables are expressed as means and standard deviations. *significantly different (p < 0.05) from the non-obese women group
Table II. Associations of plasma oxytocin levels with HOMA-IR, TC, LDL-C, and HDL-C at the selected quantile levels of 
these variables (coefficients and 95% CI)
QR†
HOMA-IR TC LDL-C HDL-C
Coefficients 95% CI Coefficients 95% CI Coefficients 95% CI Coefficients 95% CI
0.1 0.013 –0.081, 0.067 0.002 –0.177, 0.144 –0.305 –0.396, –0.132 0.076 0.044, 0.135
0.2 –0.007 –0.120, 0.041 –0.237 –0.403, –0.042 –0.206
–0.303, 
–0.109 0.114 0.068, 0.131
0.3 –0.101 –0.161, –0.015 –0.383
–0.508, 
–0.141 –0.163
–0.342, 
–0.048 0.122 0.089, 0.169
0.4 –0.125 –0.214, –0.062 –0.388
–0.605, 
–0.232 –0.206
–0.325, 
–0.079 0.139 0.065, 0.200
0.5 –0.182 –0.240, –0.074 –0.395
–0.553, 
–0.240 –0.289
–0.357, 
–0.176 0.145 0.073, 0.230
0.6 –0.164 –0.240, –0.078 –0.374
–0.532, 
–0.186 –0.323
–0.420, 
–0.226 0.181 0.071, 0.246
0.7 –0.122 –0.213, –0.057 –0.417
–0.612, 
–0.257 –0.342
–0.433, 
–0.243 0.182 0.117, 0.293
0.8 –0.113 –0.296, 0.010 –0.537 –0.674, –0.420 –0.332
–0.507, 
–0.259 0.142 0.036, 0.295
0.9 –0.116 –0.178, –0.131 –0.506
–0.620, 
–0.412 –0.467
–0.557, 
–0.293 0.133 0.020, 0.188
HOMA-IR — homeostatic model assessment for insulin resistance; TC — total cholesterol; LDL-C — low-density lipoprotein cholesterol; HDL — high-density 
lipoprotein; CI — confidence interval; †The quantile levels ranged from 0.1 to 0.9, in which the corresponding values of HOMA-IR were 1.82, 1.98, 2.15, 2.32, 2.49, 
2.64, 2.80, 3.08, and 3.38; the corresponding values of TC were 3.37, 3.77, 4.09, 4.35, 4.53, 4.86, 5.11, 5.48, and 6.00; the corresponding values of LDL-C were 1.33, 
1.65, 1.79, 1.97, 2.02, 2.12, 2.30, 2.76, and 3.14; and the corresponding values of HDL were 0.94, 1.03, 1.12, 1.21, 1.31, 1.43, 1.54, 1.73, and 1.93, respectively
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strongest at the quantile level of 0.62 (i.e. the HDL-C 
level of 1.48). 
Discussion
The purpose of this study was to examine the plasma 
oxytocin levels in obese women of childbearing age, and 
to investigate the relationship between plasma oxyto-
cin levels and metabolic parameters. In this study, we 
included FPG, FI, HOMA-IR, TC, TG, LDL-C, HDL-C, 
SBP, and DBP as evaluation indices of metabolism 
related to obesity.
We demonstrated that the obese women of re-
productive age had lower plasma oxytocin levels 
compared with non-obese women of the same age. 
This result was in agreement with some previous 
reports. However, most of the related studies were 
done on postmenopausal women or women after 
ovariectomy [14, 24]. Oxytocin is an anorexigenic neu-
ropeptide that controls metabolic homeostasis mainly 
via regulating food intake and energy expenditure 
[25]. Laboratory animal experiments also confirmed 
that oxytocin can increase brown adipose tissue ther-
mogenesis [26–28]. Despite the basic animal research 
showing beneficial effects of oxytocin on adjusting 
metabolism and losing weight, clinical studies on 
oxytocin’s therapeutic potential in human obesity are 
still in their early stages [11, 29, 30]. 
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Figure 1. Coefficients of oxytocin for the associations of plasma 
oxytocin levels and HOMA-IR across the selected quantile levels 
of HOMA-IR. HOMA-IR — homeostatic model assessment for 
insulin resistance
The quantile levels ranged from 0.1 to 0.9, in which the corresponding values 
of HOMA-IR were 1.82, 1.98, 2.15, 2.32, 2.49, 2.64, 2.80, 3.08, and 3.38, 
respectively
Figure 2. Coefficients of oxytocin for the associations of plasma 
oxytocin levels and TC across the selected quantile levels of TC. 
TC — total cholesterol
The quantile levels ranged from 0.1 to 0.9, in which the corresponding values 
of TC were 3.37, 3.77, 4.09, 4.35, 4.53, 4.86, 5.11, 5.48, and 6.00, respectively
Figure 3. Coefficients of oxytocin for the associations of plasma 
oxytocin levels and LDL-C across the selected quantile levels of 
LDL-C. LDL-C — low-density lipoprotein cholesterol
The quantile levels ranged from 0.1 to 0.9, in which the corresponding 
values of LDL-C were 1.33, 1.65, 1.79, 1.97, 2.02, 2.12, 2.30, 2.76, and 3.14, 
respectively
Figure 4. Coefficients of oxytocin for the associations of plasma 
oxytocin levels and HDL-C across the selected quantile levels of 
HDL-C. HDL — high-density lipoprotein
The quantile levels ranged from 0.1 to 0.9, in which the corresponding values of 
HDL were 0.94, 1.03, 1.12, 1.21, 1.31, 1.43, 1.54, 1.73, and 1.93, respectively
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In this study, after adjusting for age, we found that 
the plasma oxytocin levels were inversely associated 
with HOMA-IR, LC, and LDL-C, and it also showed 
an positive association with HDL-C. Moreover, we 
found that the inverse association between plasma 
oxytocin levels and HOMA-IR was seen above the 
HOMA-IR level of 2.11, and the inverse association of 
plasma oxytocin levels with TC was found above the 
TC level of 3.78 and became stronger above that level. 
We also found that the inverse association of plasma 
oxytocin levels with LDL-C was seen at all LDL-C levels 
and became stronger above the LDL level of 1.91. The 
plasma oxytocin levels showed a positive association 
with HDL-C at all levels of HDL-C, and the correlation 
was strongest at HDL-C level of 1.48. 
These results suggest for the first time that oxytocin 
played an important role in inhibiting obesity-related 
metabolic disorders, including insulin resistance and 
dyslipidaemia, and the association between oxytocin 
and dyslipidaemia was more significant. Furthermore, 
the higher the TC and LDL-C levels, the more signifi-
cant the correlations. In this study, we selected obese 
women in reproductive age as the research group after 
excluding pathological obesity caused by metabolic or 
endocrine diseases. These research subjects had normal 
ovarian function and menstrual cycle. Therefore, the 
differences between the variables of the two groups 
were small, and the association between them may be 
weak. Hence, quantile regression analysis was used in 
this study. The regression coefficients of the variables 
in the quantile regression model differ across the se-
lected quantile levels of dependent variables, which is 
very useful to investigate the associations between the 
variables in which there may be only weak associations 
between the variables. 
A previous study revealed that oxytocin showed 
negative correlation with FI and HOMA in obese 
women with polycystic ovary syndrome [31]. Another 
study showed that oxytocin concentration correlated 
negatively with glycated haemoglobin (HbA1c) and 
FPG in diabetic metabolic syndrome patients [32]. In 
this study, we failed to observe an obvious relationship 
between oxytocin and serum insulin levels and blood 
sugar levels. Such results may be due to the differ-
ent subjects included in the study. So far, few studies 
have examined the relationship between oxytocin and 
blood lipid or lipoprotein, and the findings have been 
inconsistent; in some of them there were no statistically 
significant relationships between oxytocin and lipid 
levels [17, 33, 34]. One of the studies investigated the 
associations between oxytocin and glycolipid metabo-
lism in type 2 diabetes patients and obtained ideal con-
clusions. They found that serum oxytocin levels were 
negatively correlated with TC, TG, and LDL-C [17]. 
Because the metabolic disorders in diabetes patients are 
more obvious, it is easier to gain a positive conclusion 
in research on the correlation between oxytocin and 
metabolic parameters. In our study, the difference in 
metabolic parameters between obese women of child-
bearing age and non-obese women was not significant, 
especially blood glucose and blood pressure, so we did 
not draw corresponding positive conclusions.
One limitation of our study was that the sample 
size was small. A larger cohort is needed to investigate 
plasma oxytocin levels in obese women of reproduc-
tive age and their relationship with metabolic param-
eters. Another limitation was that the gonadal axis and 
its association with oxytocin were not evaluated in this 
study. In females, oxytocin secretion is affected by the 
function of the ovaries [20, 35]. One study showed that 
17b-oestradiol increased expression of oxytocin mRNA 
in the paraventricular nucleus of the hypothalamus and 
then increased plasma oxytocin protein levels [36]. In the 
future, further studies are needed to expand the study 
variables in order to obtain more reliable conclusions. 
In this study, the results suggest that oxytocin 
plays an important role in inhibiting metabolic disor-
ders. Therefore, our future implementation of oxyto-
cin-based studies will focus on its therapeutic effects 
on controlling body weight, energy balance, glucolipid 
metabolism, and insulin resistance. Moreover, early stud-
ies have looked at changes in plasma oxytocin levels after 
weight loss. It was found that plasma levels of oxytocin 
were almost four-fold higher in obese people after weight 
reduction following gastric banding [37]. However, few 
studies have investigated the effects of weight-loss drugs 
on levels of oxytocin. Future research will also look at 
the effects of some anti-obesity drugs on oxytocin levels. 
Conclusions
Oxytocin deficiency was common in obese women of 
childbearing age. Oxytocin showed a negative correla-
tion with HOMA-IR, TC, and LDL-C, while it showed 
a positive association with HDL-C. Furthermore, the 
higher the TC and LDL-C levels, the more significant 
the correlations. Our findings suggested that oxytocin 
played an important role in inhibiting metabolic disor-
ders associated obesity in women of childbearing age.
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